


Pediatric Kidney Transplant Success Rate in India
Access high-quality treatment through JCI & NABH-accredited hospitals, renowned specialists, and end-to-end medical travel support designed around your healing journey.
Plan My Journey
Tell us your condition and budget - our AI matches the right destination, hospital and doctor and visa pathway
Cost calculator
I know my treatment - show me cost from 3 hospitals
5K+ International Patients Treated
40+ Source Countries Served
500+ Accredited Partner Hospitals
98% Patient Satisfaction
80% Average Savings vs USA
10K+ Doctors
NABH, JCI Accredited Hospitals
Free Treatment Plan
Free Consultation with Doctor
5+ Destinations Covered
Written by DivinHeal Editorial Contributor, DivinHeal Medical Team, Healthcare Advisory Team Published on: February 19, 2026
About
Pediatric Kidney Transplant Success Rate in India
Understanding the Pediatric Kidney Transplant success rate in India is crucial for families navigating complex healthcare decisions. Outcomes depend significantly on factors like the child's overall health, the stage of kidney disease, and the specific transplant approach. India has emerged as a prominent destination, with specialized centers providing advanced pediatric renal care, drawing on extensive clinical expertise and comprehensive patient management protocols.
The Pediatric Kidney Transplant survival rate in India is rigorously reviewed, drawing from aggregated clinical data and multi-center studies to provide a clearer picture. These outcomes are systematically evaluated against various treatment parameters, patient profiles, and pre-existing conditions. Understanding these variations helps families to make confident and informed healthcare decisions regarding their child's treatment journey.
Defining Success in Pediatric Kidney Transplant
For Pediatric Kidney Transplant, "success" is primarily defined by long-term graft survival—the transplanted kidney functioning effectively—and the child's improved quality of life. This includes freedom from dialysis, normal growth and development, and the ability to participate in age-appropriate activities. Success also encompasses the patient's overall health and the absence of significant post-transplant complications, distinguishing between short-term stability and sustained, long-term well-being.
Pediatric Kidney Transplant Success Rate Breakdown
Pediatric Kidney Transplant recovery rate in India varies depending on the specific type of transplant and the donor source.
| Treatment Type / Category | Typical Use Case | Success Rate Range (%) | What Success Indicates |
|---|---|---|---|
| Living Donor Transplant | Children with chronic kidney disease (CKD) receiving a kidney from a living relative or compatible donor. | 90%–98% | Excellent long-term graft survival, improved growth, enhanced quality of life, reduced risk of rejection. |
| Deceased Donor Transplant | Children with CKD receiving a kidney from a deceased donor, often following a period on a waiting list. | 85%–95% | Good graft survival rates, return to normal activities, freedom from dialysis, management of potential complications. |
Pediatric Kidney Transplant Survival Rate by Age in India and Stage-wise Outcomes
The stage wise Pediatric Kidney Transplant survival rate in India, alongside age-specific outcomes, reflects globally observed clinical trends. Younger children, especially infants, may present unique surgical and immunological challenges, impacting their success rates. Older children and adolescents often show outcomes closer to adult transplant recipients.
| Age Group / Patient Category | Treatment Method | Success Rate Range (%) |
|---|---|---|
| Infants (<2 years) | Living or Deceased Donor Transplant | 80%–90% |
| Young Children (2–12 years) | Living or Deceased Donor Transplant | 88%–96% |
| Adolescents (13–18 years) | Living or Deceased Donor Transplant | 90%–98% |
India vs Global Pediatric Kidney Transplant Success Rate Comparison
Success rates for Pediatric Kidney Transplant in India are comparable with international standards, particularly in leading centers that adhere to rigorous protocols, employ advanced technology, and maintain strict patient selection criteria. These outcomes align well with those observed in other prominent global healthcare destinations.
| Country | Treatment Success Rate Range (%) |
|---|---|
| India | 88%–98% |
| United States | 90%–98% |
| United Kingdom | 88%–97% |
| Germany | 89%–97% |
| Singapore | 90%–98% |
| Turkey | 87%–96% |
| Thailand | 86%–95% |
Please note that these success rates are indicative and can vary based on individual patient circumstances and the specific clinical setting.
Factors That Influence Success Rate
- Recipient's age and overall health condition before transplant.
- Immunological compatibility between the donor and the recipient.
- Presence of other co-morbidities or underlying medical conditions.
- Quality of the donor organ, whether from a living or deceased donor.
- Expertise of the surgical team and post-operative care management.
- Adherence to immunosuppressant medication regimen and follow-up.
- Timeliness of intervention and absence of pre-existing complications.
Data Sources & Methodology
- National Organ and Tissue Transplant Organization (NOTTO) data.
- Peer-reviewed medical literature and clinical trial outcomes.
- Aggregated multi-institutional data from specialized transplant centers.
- International transplant registries and comparative studies.
- Leading centers such as AIIMS, Tata Memorial Centre, and major institutes follow evidence-based protocols.
Informed Choices for Pediatric Transplants
Understanding the nuances of transplant outcomes helps families make well-informed healthcare decisions. Prioritize comprehensive discussions with medical professionals to clarify individual prognostic factors and expected results.
Hospitals
NABH & JCI Accredited Hospitals in India,Turkey, Thailand & UAE.

Artemis Hospital
Sector 51, Gurugram, Haryana, India

Lokmanya Hospitals
Not Specified

White Lotus Hospital
766, SFS 3145, SFS Road, 7th Sector, HSR Layout, Bengaluru, Karnataka 560102, India

Institute of Brain and Spine (IBS Hospital)
Not Specified
Meet Our Medical Specialists




Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India





Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India

How DivinHeal Helps
We simplify your medical journey by providing comprehensive support and access to world-class healthcare.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Accredited Hospital Network
Access to JCI & NABH certified healthcare facilities.
Complete Travel Coordination
Hassle-free visa, stay, and local transport assistance.
24/7 Personal Care
Dedicated patient advisors supporting you at every step.
Journey Guidance
Full guidance from start to end of the patient treatment journey.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Everything you
need to know today
Browse through these common inquiries to better understand our patient-focused medical platform.
Yes, we work with a variety of insurance providers. Contact our team to verify your coverage.
Yes, we provide secure online consultations with experienced specialists.
Our care coordinators help match you with the most suitable specialist.
Absolutely. Your medical information is protected according to healthcare privacy standards.
Look at six things: accreditation (JCI or NABH), specialty depth, doctor credentials and experience, procedure-specific success rates, international patient support, and technology. DivinHeal's AI-driven matching evaluates every hospital in our accredited partner network on these dimensions and shortlists the best-fit options for your condition, budget, and country.
JCI (Joint Commission International) is the US-based global gold standard for hospital quality, recognised worldwide. NABH is India's national accreditation — accredited by ISQua, the same body that accredits JCI. Both signal independently verified safety and quality. Most of India's leading hospitals hold both.
Yes. All three welcome international patients through structured medical visa programs. India is the most established, treating patients from Africa, the Middle East, and South Asia at 60–80% lower cost. Thailand leads in cosmetic and dental care. The UAE is emerging in oncology and reproductive medicine.
Most patients save 50–80% on treatment costs. Heart bypass costs US $7,000–9,000 in India compared to $70,000–150,000 in the US. IVF costs $3,000–4,500 compared to $12,000–20,000 in the UK. Even after flights, visa, and accommodation, total savings remain 60–70%.
DivinHeal manages your entire non-medical journey: visa invitation letters, medical visa guidance, doctor appointments, teleconsultations, airport pickup, hospital-vetted accommodation for you and your attendant, language interpreters, local transport, cuisine preferences, and post-treatment follow-up — one dedicated coordinator from first enquiry to final follow-up.
You need a valid passport (6+ months validity), a medical visa (M-Visa for India — DivinHeal provides the hospital invitation letter), return flight tickets, recent medical reports and a doctor's referral, current prescription list, and proof of financial means. Any accompanying attendant needs their own passport and MX-Visa.
Still have more questions?
Book a call with our friendly team to learn how DivineHeal simplifies your healthcare journey.